NewEdge Advisors LLC Has $9.14 Million Holdings in Cigna Group $CI

NewEdge Advisors LLC grew its stake in Cigna Group (NYSE:CI) by 47.8% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 34,277 shares of the health services provider’s stock after purchasing an additional 11,085 shares during the period. NewEdge Advisors LLC’s holdings in Cigna Group were worth $9,143,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. lifted its stake in shares of Cigna Group by 1.6% in the fourth quarter. Vanguard Group Inc. now owns 26,173,577 shares of the health services provider’s stock valued at $7,203,754,000 after buying an additional 414,834 shares during the period. State Street Corp increased its stake in Cigna Group by 1.8% during the fourth quarter. State Street Corp now owns 12,339,250 shares of the health services provider’s stock valued at $3,396,132,000 after acquiring an additional 224,122 shares during the period. Dodge & Cox raised its holdings in Cigna Group by 19.7% in the 4th quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock valued at $3,065,681,000 after acquiring an additional 1,833,389 shares in the last quarter. GQG Partners LLC raised its holdings in Cigna Group by 14.3% in the 4th quarter. GQG Partners LLC now owns 7,763,295 shares of the health services provider’s stock valued at $2,136,699,000 after acquiring an additional 972,302 shares in the last quarter. Finally, Geode Capital Management LLC lifted its position in shares of Cigna Group by 0.8% in the 4th quarter. Geode Capital Management LLC now owns 6,051,370 shares of the health services provider’s stock worth $1,658,055,000 after acquiring an additional 48,474 shares during the period. Institutional investors own 86.99% of the company’s stock.

Insider Transactions at Cigna Group

In other news, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the sale, the chief executive officer directly owned 34,337 shares in the company, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. This represents a 27.52% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 222,213 shares of company stock worth $64,751,950. Insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the company. Piper Sandler decreased their price objective on Cigna Group from $370.00 to $346.00 and set an “overweight” rating on the stock in a report on Wednesday, June 3rd. UBS Group raised their target price on Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a research report on Friday, May 22nd. Wall Street Zen downgraded shares of Cigna Group from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Guggenheim increased their price objective on shares of Cigna Group from $338.00 to $361.00 and gave the company a “buy” rating in a research note on Friday, July 31st. Finally, Barclays raised their price objective on shares of Cigna Group from $304.00 to $310.00 and gave the stock an “equal weight” rating in a report on Friday, July 31st. Fifteen research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Cigna Group has an average rating of “Moderate Buy” and a consensus price target of $339.45.

Cigna Group Stock Performance

NYSE:CI opened at $281.95 on Monday. Cigna Group has a 1 year low of $239.51 and a 1 year high of $315.47. The firm has a 50 day moving average of $286.00 and a 200-day moving average of $281.26. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $74.50 billion, a P/E ratio of 11.67, a price-to-earnings-growth ratio of 0.97 and a beta of 0.29.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The business had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. During the same period in the previous year, the business earned $7.20 EPS. Cigna Group’s revenue was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, sell-side analysts anticipate that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Tuesday, September 8th. Cigna Group’s dividend payout ratio is presently 25.82%.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.